266 related articles for article (PubMed ID: 26586706)
1. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
Ataş H; Cemil BC; Canpolat F; Gönül M
Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
Ataş H; Canpolat F; Eskioglu F
Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
Balkarli A; Kucuk A; Babur H; Erbasan F
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
[TBL] [Abstract][Full Text] [Related]
4. Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet's disease without significant cardiovascular involvement.
Balta I; Balta S; Koryurek OM; Demirkol S; Celik T; Akbay G; Cakar M; Sarlak H; Eksioglu M
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1388-93. PubMed ID: 24164056
[TBL] [Abstract][Full Text] [Related]
5. Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.
Ricart JM; España F; Navarro S; Todolí J; Miguel De la Fuente J; Vayá A
Clin Hemorheol Microcirc; 2013 Jan; 54(1):51-7. PubMed ID: 22750994
[TBL] [Abstract][Full Text] [Related]
6. Is mean platelet volume a new activity criteria in Behçet's disease?
Uzkeser H; Haliloglu S; Cayir Y; Bilen N; Karaaslan Y; Kosar A; Carlioglu A
Blood Coagul Fibrinolysis; 2015 Oct; 26(7):836-9. PubMed ID: 26196194
[TBL] [Abstract][Full Text] [Related]
7. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
8. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
9. Increased mean platelet volume in Behçet's disease with thrombotic tendency.
Acikgoz N; Karincaoglu Y; Ermis N; Yagmur J; Atas H; Kurtoglu E; Cansel M; Barutcu I; Pekdemir H; Ozdemir R
Tohoku J Exp Med; 2010 Jun; 221(2):119-23. PubMed ID: 20484842
[TBL] [Abstract][Full Text] [Related]
10. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study.
Pamuk GE; Pamuk ON; Orüm H; Demir M; Turgut B; Cakir N
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):113-7. PubMed ID: 20135752
[TBL] [Abstract][Full Text] [Related]
11. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
12. Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease.
Ryu HJ; Seo MR; Choi HJ; Ko KP; Park PW; Baek HJ
Int J Rheum Dis; 2018 Aug; 21(8):1640-1645. PubMed ID: 27886446
[TBL] [Abstract][Full Text] [Related]
13. Major arterial involvement and review of Behcet's disease.
Alpagut U; Ugurlucan M; Dayioglu E
Ann Vasc Surg; 2007 Mar; 21(2):232-9. PubMed ID: 17349371
[TBL] [Abstract][Full Text] [Related]
14. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status in patients with Behcet's Disease.
Karatay S; Yildirim K; Karakuzu A; Kiziltunc A; Engin RI; Eren YB; Aktas A
Clinics (Sao Paulo); 2011; 66(5):721-3. PubMed ID: 21789370
[TBL] [Abstract][Full Text] [Related]
16. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Atıl A; Deniz A
Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
[TBL] [Abstract][Full Text] [Related]
17. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
[TBL] [Abstract][Full Text] [Related]
18. The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet's syndrome.
Alan S; Tuna S; Türkoğlu EB
Kaohsiung J Med Sci; 2015 Dec; 31(12):626-31. PubMed ID: 26709224
[TBL] [Abstract][Full Text] [Related]
19. Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
Goktaş MT; Hatta F; Karaca O; Kalkisim S; Kilic L; Akdogan A; Babaoglu MO; Bozkurt A; Helldén A; Bertilsson L; Yasar U
Eur J Clin Pharmacol; 2015 Oct; 71(10):1223-8. PubMed ID: 26233334
[TBL] [Abstract][Full Text] [Related]
20. The hyperchemotaxis of Behcet's disease and the effect of colchicine.
Baum J
J Rheumatol; 1981; 8(1):171-2. PubMed ID: 7218250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
